Inhibition of protein synthesis reduces the cytotoxicity of 4'-(9-acridinylamino) methane-sulfon-m-anisidide without affecting DNA breakage and DNA topoisomerase ii in a murine mastocytoma cell line

This publication has 21 references indexed in Scilit:

• Mechanism of resistance of non-cycling mammalian cells to 4′-[9-acridinylamino]methanesulphon-m-anisidide: Role of DNA topoisomerase II in log- and plateau-phase CHO cells
  Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1988
• Topoisomerase-specific drug sensitivity in relation to cell cycle progression.
  Molecular and Cellular Biology, 1987
• Cell cycle stage-dependent variations in drug-induced topoisomerase II mediated DNA cleavage and cytotoxicity
  Biochemistry, 1987
• The interaction between nuclear topoisomerase II activity from human leukemia cells, exogenous DNA, and 4′-(9-acridinylamino) methanesulfon-m-anisidide (m-AMSA) or 4-(4,6-0-ethylidene-β-D-glucopyranoside) (VP-16) indicates the sensitivity of the cells to the drugs
  Biochemical and Biophysical Research Communications, 1987
• Proliferation dependence of topoisomerase II-mediated drug action
  Biochemistry, 1986
• DNA topoisomerases as targets for cancer therapy
  Biochemical Pharmacology, 1985
• DNA topoisomerase II as a target of antineoplastic drug therapy
  Cancer and Metastasis Reviews, 1985
• Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase II
  Science, 1984
• Dominant versus recessive behavior of a cold- and a heat-sensitive mammalian cell cycle variant in heterokaryons
  Somatic Cell and Molecular Genetics, 1981
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976